BioCryst Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

BioCryst Pharmaceuticals

04/11/2024 15:26

* BioCryst Pharmaceuticals Inc  BCRX.OQ  reported a
quarterly
adjusted loss of 7 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -19 cents.  The mean expectation of
ten analysts for the quarter was for a loss of 6 cents per
share. Wall Street expected results to range from -9 cents to -3
cents per share.
    * Revenue rose 35% to $117.09 million from a year ago;
analysts
expected $112.50 million. 
    * BioCryst Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 7 cents​.
    * The company reported a quarterly loss of $14.03 million.
    * BioCryst Pharmaceuticals Inc shares had risen by 10.9%
this
quarter and gained 40.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 30.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for BioCryst
Pharmaceuticals Inc is 11.00 
This summary was machine generated from LSEG data November 4 at
03:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.06          -0.07          Missed
 Jun. 30 2024      -0.17          -0.06          Beat
 Mar. 31 2024      -0.21          -0.17          Beat
 Dec. 31 2023      -0.24          -0.28          Missed